Figure 8 | Scientific Reports

Figure 8

From: Lipidomic-based investigation into the regulatory effect of Schisandrin B on palmitic acid level in non-alcoholic steatotic livers

Figure 8

SchB treatment affects the plasma cholesterol levels in fasting mice.

(A) 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase activity, (B) total cholesterol, (C) VLDL/LDL cholesterol and (F) HDL cholesterol of non-fasting (nf), fasting (f) and HFD-fed (HFD) mice. Expressions of LDL receptor in (D) livers, bar charts showing the mean ± SE (n = 4 mice in each group), *p < 0.05 and in (E) FFA-treated MIHA cells, bar chart showing the mean ± SE (n = 3 independent experiments), *p < 0.05. f-veh: fasting vehicle control group; f-SchB: fasting SchB-treated group. Full length blots were shown in Supplementary S9.

Back to article page